SCHEMBL7305192

SCHEMBL7305192

CCOC(=O)Nc1ccc(C2CCN(OC(=O)OC(C)(C)C)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.47
LMNA P02545 2/20 0.45
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.41
SLC18A3 Q16572 1/20 0.41
HPGD P15428 2/20 0.41
CYP1A2 P05177 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
KMT2A Q03164 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MMP8 P22894 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27322968 0.90 LMNA (0.47) NAMPTLMNAMAPTMAPK1SLC18A3
SCHEMBL7300880 0.90 LMNA (0.49) NAMPTLMNAMAPTMAPK1SLC18A3
SCHEMBL8986417 0.84 NAMPT (0.65) NAMPTLMNAMAPTMAPK1RAB9A
SCHEMBL1996214 0.80 NAMPT (0.57) NAMPTLMNAMAPTSMN1; SMN2RAB9A
SCHEMBL1996211 0.80 NAMPT (0.57) NAMPTLMNAMAPTSMN1; SMN2RAB9A
SCHEMBL8986471 0.79 MAPT (0.58) NAMPTLMNAMAPTHPGDKMT2A
SCHEMBL7303971 0.78 SLC18A3 (0.42) NAMPTMAPTMAPK1SLC18A3RAB9A
SCHEMBL187122 0.77 P2RY14 (0.41) NAMPTMAPTKMT2A
SCHEMBL10813817 0.76 LMNA (0.61) LMNAHPGDCYP1A2SMN1; SMN2RAB9A
SCHEMBL8986418 0.76 LMNA (0.61) LMNAHPGDCYP1A2SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0657440-B1 Oxazolidine-2-one derivatives as MAO inhibitors HOFFMANN LA ROCHE (CH) 2000-04-05 EP disclosed
EP-0657440-A1 Oxazolidine-2-one derivatives F. HOFFMANN-LA ROCHE AG (CH) 1995-06-14 EP disclosed